EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.14.11.4 | procollagen-lysine 5-dioxygenase |
MDA-MB-435 cell |
- |
725955 |
1.14.11.53 | mRNA N6-methyladenine demethylase |
MDA-MB-435 cell |
- |
739559 |
2.4.1.144 | beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
MDA-MB-435 cell |
- |
703956 |
2.4.1.149 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase |
MDA-MB-435 cell |
- |
706504 |
2.4.1.150 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase |
MDA-MB-435 cell |
- |
758992 |
2.4.1.155 | alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase |
MDA-MB-435 cell |
- |
703956 |
2.4.1.50 | procollagen galactosyltransferase |
MDA-MB-435 cell |
- |
725955 |
2.7.1.32 | choline kinase |
MDA-MB-435 cell |
- |
672898 |
2.7.10.2 | non-specific protein-tyrosine kinase |
MDA-MB-435 cell |
- |
694492 |
2.7.11.22 | cyclin-dependent kinase |
MDA-MB-435 cell |
- |
681873, 691256 |
2.7.11.22 | cyclin-dependent kinase |
MDA-MB-435 cell |
breast carcinoma cell line |
665977 |
2.7.11.30 | receptor protein serine/threonine kinase |
MDA-MB-435 cell |
breast carcinoma cell line, derived from malignant pleural effusions |
663984 |
3.1.3.2 | acid phosphatase |
MDA-MB-435 cell |
- |
679089 |
3.1.4.11 | phosphoinositide phospholipase C |
MDA-MB-435 cell |
- |
691606 |
3.1.4.39 | alkylglycerophosphoethanolamine phosphodiesterase |
MDA-MB-435 cell |
- |
705057 |
3.2.1.166 | heparanase |
MDA-MB-435 cell |
- |
694315 |
3.2.1.35 | hyaluronoglucosaminidase |
MDA-MB-435 cell |
- |
703231 |
3.4.19.9 | folate gamma-glutamyl hydrolase |
MDA-MB-435 cell |
- |
731560 |
3.4.19.9 | folate gamma-glutamyl hydrolase |
MDA-MB-435 cell |
gamma-glutamyl hydrolase overexpression decreases global DNA methylation and DNA methyltransferase activity, while gamma-glutamyl hydrolase inhibition increases global DNA methylation and DNA methyltransferase activity. gamma-Glutamyl hydrolase modulation influences CpG promoter DNA methylation and gene expression involved in important biological pathways including cell cycle, cellular development, and cellular growth and proliferation |
731880 |
3.4.21.109 | matriptase |
MDA-MB-435 cell |
RT-PCR analysis reveal a 1000fold higher matriptase expression in human pancreatic adenocarcinoma AsPC-1 cells than in the MDA-MB-435S cells |
708768 |
3.4.21.73 | u-Plasminogen activator |
MDA-MB-435 cell |
- |
698349, 710163 |
3.4.21.75 | Furin |
MDA-MB-435 cell |
- |
732774 |
3.4.22.1 | cathepsin B |
MDA-MB-435 cell |
- |
697074 |
3.4.22.15 | cathepsin L |
MDA-MB-435 cell |
- |
678521, 698768 |
3.4.22.38 | cathepsin K |
MDA-MB-435 cell |
- |
697375 |
3.4.24.18 | meprin A |
MDA-MB-435 cell |
- |
733064 |
3.4.24.35 | gelatinase B |
MDA-MB-435 cell |
- |
696965 |
3.4.24.7 | interstitial collagenase |
MDA-MB-435 cell |
high MMP-1 level |
708587 |
3.4.24.B7 | matrix metalloproteinase-26 |
MDA-MB-435 cell |
- |
668149 |
4.1.1.17 | ornithine decarboxylase |
MDA-MB-435 cell |
breast cancer cell line |
695299 |
5.6.2.1 | DNA topoisomerase |
MDA-MB-435 cell |
- |
727417 |
5.6.2.1 | DNA topoisomerase |
MDA-MB-435 cell |
a breast cancer cell line |
705061 |
5.6.2.1 | DNA topoisomerase |
MDA-MB-435 cell |
breast cancer cell line |
693543 |
5.6.2.1 | DNA topoisomerase |
MDA-MB-435 cell |
MDA-MB-435MGM cell |
693562 |
6.3.2.17 | tetrahydrofolate synthase |
MDA-MB-435 cell |
- |
745594 |
6.4.1.1 | pyruvate carboxylase |
MDA-MB-435 cell |
- |
746189 |
7.4.2.5 | bacterial ABC-type protein transporter |
MDA-MB-435 cell |
- |
700137 |